Pharmaceuticals
Healthcare
Wockhardt gets warning from USFDA over Chikalthana plant at Aurangabad
In another setback to Mumbai-based generic drugmaker Wockhardt Ltd, it has received an import alert from US Food and Drug ......
Healthcare
Bafna Pharmaceuticals looking to raise capital; Mylan said to be among suitors
Chennai-based small size drugmaker Bafna Pharmaceuticals Ltd is looking at various options to raise capital, as per a stock market ......
Healthcare
Pfizer consolidating Indian units, to hold 63% after merging Wyeth
The world’s largest drug maker Pfizer is consolidating two public listed arms in India by merging Wyeth Ltd with Pfizer ......
Healthcare
Torrent Pharma in race for part of Elder Pharmaceuticals
Ahmedabad-based drugmaker Torrent Pharmaceuticals Ltd has submitted a non-exclusive bid to acquire certain businesses of Elder Pharmaceuticals Ltd, it disclosed ......
Healthcare
Cipla hikes stake in Quality Chemical to 51.05% for $15M
Cipla, through its wholly-owned subsidiary Meditab Holdings Ltd (MHL), has acquired an additional 14.5 per cent stake in Quality Chemical ......
Healthcare
Avesthagen Pharma signs pact with Elpen to distribute biosimilar
Villoo Patell-promoted Avesthagen Pharma AG (APAG) has signed an agreement with Greek life science company Elpen Pharmaceuticals to distribute its ......
Healthcare
US-based Perrigo acquiring 15% stake held by local partners in Indian arm
US-based OTC and generic pharmaceutical maker Perrigo Company is investing Rs 130 crore in its local arm to raise its ......
Healthcare
ChrysCapital-backed Ipca acquiring 50% of Avik for $1M
ChrysCapital-backed pharmaceutical major Ipca Laboratories Ltd is acquiring 50 per cent of Gujarat-based Avik Pharmaceuticals Ltd for Rs 6.51 crore ......
Healthcare
Sun Pharma Q2 net profit quadruples; raises revenue growth outlook
Sun Pharmaceuticals Ltd, the country’s largest drug-maker by market capitalisation, posted strong revenues and a four-fold increase in net profit ......
Healthcare
GSK Pharma's profit tumbles amid drug price row
Drug maker GlaxoSmithKline Pharmaceuticals Ltd’s net profit tumbled by 33 per cent to Rs 100.9 crore for quarter ended September ......